Roche's quarterly sales declined 6% as a slump in COVID treatments and diagnostic testing outweighed gains from hemophilia and multiple sclerosis…

Booming sales of virus test kits helped to offset a drop in drug sales at Swiss pharmaceuticals giant Roche.